By Will Feuer AstraZeneca said it has filed a legal challenge to certain aspects of the drug price negotiation provisions of the Inflation Reduction Act,.
By Michael Susin AstraZeneca's prostate-cancer treatment Lynparza has been approved in Japan, while Soliris has been approved for expanded use to treat.
By Dominic Chopping Renewable energy producer Statkraft said it has entered a wind power agreement with AstraZeneca that sees the Anglo-Swedish pharma giant.